Skip to Content

19 Results Found

  • Article
  • Open Access
2 Citations
1,974 Views
15 Pages

Live Cell Monitoring of Phosphodiesterase Inhibition by Sulfonylurea Drugs

  • Filip Berisha,
  • Stefan Blankenberg and
  • Viacheslav O. Nikolaev

10 August 2024

Sulfonylureas (SUs) are a class of antidiabetic drugs widely used in the management of diabetes mellitus type 2. They promote insulin secretion by inhibiting the ATP-sensitive potassium channel in pancreatic β-cells. Recently, the exchange prote...

  • Article
  • Open Access
12 Citations
3,091 Views
38 Pages

Glycosylphosphatidylinositol-anchored proteins (GPI-APs) are anchored at the outer leaflet of eukaryotic plasma membranes (PMs) only by carboxy-terminal covalently coupled GPI. GPI-APs are known to be released from the surface of donor cells in respo...

(This article belongs to the Special Issue Molecular Advances on Insulin Resistance and Metabolic Dysfunction)
  • Article
  • Open Access
23 Citations
5,240 Views
14 Pages

6 November 2020

Accelerated microbial degradation following previous repeated applications of the same pesticide, or another pesticide of a similar chemical structure, is a known phenomenon. Currently there is limited information regarding accelerated degradation of...

(This article belongs to the Special Issue Weed Management & Sustainable Agriculture)
  • Article
  • Open Access
17 Citations
4,117 Views
14 Pages

25 January 2023

Herein, an ultrasensitive lateral flow immunoassay (LFIA), based on metal-organic framework-decorated polydopamine (PCN-224@PDA) was first established to detect multiple sulfonylureas (SUs) in functional foods. The PCN-224@PDA was synthesized using t...

(This article belongs to the Section Food Analytical Methods)
  • Article
  • Open Access
7 Citations
3,027 Views
13 Pages

Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study

  • Fu-Shun Yen,
  • James Cheng-Chung Wei,
  • Teng-Shun Yu,
  • Chung Y. Hsu,
  • Chih-Cheng Hsu and
  • Chii-Min Hwu

We conducted this study to investigate the long-term outcomes of sulfonylurea (SU) use in patients with chronic obstructive pulmonary disease (COPD) and type 2 diabetes (T2D). We used propensity-score matching to identify 6008 pairs of SU users and n...

(This article belongs to the Special Issue Chronic Conditions: Issues and Challenges)
  • Article
  • Open Access
9 Citations
7,936 Views
15 Pages

Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan

  • Tomomi Kimura,
  • Kazuhito Shiosakai,
  • Yasuaki Takeda,
  • Shinji Takahashi,
  • Masahiko Kobayashi and
  • Motonobu Sakaguchi

19 September 2012

After the launch of dipeptidyl peptidase-4 (DPP-4), a new oral hypoglycemic drug (OHD), in December 2009, severe hypoglycemia cases were reported in Japan. Although the definite cause was unknown, co-administration with sulfonylureas (SU) was suspect...

(This article belongs to the Special Issue Drug Safety and Pharmacovigilance)
  • Article
  • Open Access
41 Citations
5,430 Views
10 Pages

28 December 2018

Background: Type 2 diabetes is related to an increased risk of dementia. Preclinical studies of dipeptidyl peptidase-IV inhibitors (DPP-4i) for dementia have yielded promising results. Therefore, we investigated the risk of dementia in elderly patien...

(This article belongs to the Special Issue Clinical Research on Diabetic Complications)
  • Article
  • Open Access
6 Citations
3,507 Views
27 Pages

Combining Sulfonylureas with Anticancer Drugs: Evidence of Synergistic Efficacy with Doxorubicin In Vitro and In Vivo

  • Mateusz D. Tomczyk,
  • Karolina Matczak,
  • Marta Denel-Bobrowska,
  • Grzegorz Dzido,
  • Anna Kubicka,
  • Daria Gendosz de Carrillo,
  • Tomasz Cichoń,
  • Marlena Golec,
  • Beata Powieczko and
  • Horacio Pérez-Sánchez
  • + 2 authors

8 February 2025

Sulfonylureas (SUs)—a class of drugs primarily used to treat type 2 diabetes—have recently attracted interest for their potential anticancer properties. While some studies have explored the chemical modification or design of new SU deriva...

(This article belongs to the Collection Anticancer Drug Discovery and Development)
  • Abstract
  • Open Access
1,626 Views
1 Page

In soybean cropping, sulfonylurea (SU) herbicides are a potentially useful alternative to glyphosate-based herbicides. Normally, soybeans are susceptible to SU herbicides, but two unlinked non-GMO genes (ALS1 and ALS2), have been identified that conf...

(This article belongs to the Proceedings of The Third International Tropical Agriculture Conference (TROPAG 2019))
  • Article
  • Open Access
784 Views
16 Pages

Class-Specific Immunochromatographic Assay Enabled by Mesoporous Nanozyme-Catalyzed Signal Amplification for On-Site Screening of Sulfonylureas

  • Yanting Li,
  • Zixian He,
  • Pengjie He,
  • Zixuan Tang,
  • Esra Bağda,
  • Efkan Bağda,
  • Zhenlin Xu and
  • Xiangmei Li

7 March 2026

Conventional immunochromatographic assays (ICAs) face limitations in sensitivity and dynamic range, hindering their application in on-site, class-specific screening of sulfonylurea (SU) adulteration in functional foods. To address this, a signal ampl...

(This article belongs to the Section Food Analytical Methods)
  • Article
  • Open Access
14 Citations
3,850 Views
16 Pages

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis

  • György Jermendy,
  • Zoltán Kiss,
  • György Rokszin,
  • Zsolt Abonyi-Tóth,
  • Csaba Lengyel,
  • Péter Kempler and
  • István Wittmann

1 October 2022

Background and objectives: In the last couple of years, pharmacological management of patients with type 2 diabetes mellitus (T2DM) have been markedly renewed. The aim of this study was to analyse the changes in prescribing patterns of antidiabetic d...

(This article belongs to the Section Endocrinology)
  • Article
  • Open Access
27 Citations
5,632 Views
11 Pages

Circadian Clock Component BMAL1 in the Paraventricular Nucleus Regulates Glucose Metabolism

  • Masanori Nakata,
  • Parmila Kumari,
  • Rika Kita,
  • Nanako Katsui,
  • Yuriko Takeuchi,
  • Tomoki Kawaguchi,
  • Toshiya Yamazaki,
  • Boyang Zhang,
  • Shigeki Shimba and
  • Toshihiko Yada

15 December 2021

It is suggested that clock genes link the circadian rhythm to glucose and lipid metabolism. In this study, we explored the role of the clock gene Bmal1 in the hypothalamic paraventricular nucleus (PVN) in glucose metabolism. The Sim1-Cre-mediated del...

(This article belongs to the Special Issue Functional Foods: Regulation of Metabolism from Molecule to System and Disease Control)
  • Article
  • Open Access
875 Views
22 Pages

Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction?

  • Izabela Szymczak-Pajor,
  • Józef Drzewoski,
  • Sylwia Wenclewska,
  • Aneta Rogalska and
  • Agnieszka Śliwińska

The current literature indicates that type 2 diabetes (T2DM) significantly increases the risk of cancer, including pancreatic cancer (PC). While metformin’s primary role is the management of T2DM, its utility extends to systemic anti-cancer eff...

(This article belongs to the Special Issue Molecular Mechanisms and Therapies of Pancreatic Cancer: 3rd Edition)
  • Article
  • Open Access
5 Citations
3,488 Views
12 Pages

25 February 2023

This study was conducted to develop a novel herbicide resistance soybean using ethyl methanesulfonate (EMS) mutagen. In this study, 0.1% of EMS mutagen was applied to the soybean [Glycine max (L.) cv Arısoy] seeds. A single resistant mutant was...

(This article belongs to the Section Crop Genetics, Genomics and Breeding)
  • Article
  • Open Access
23 Citations
3,403 Views
10 Pages

The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes

  • Giuseppe Defeudis,
  • Alfonso Maria Di Tommaso,
  • Claudia Di Rosa,
  • Danilo Cimadomo,
  • Yeganeh Manon Khazrai,
  • Antongiulio Faggiano,
  • Raffaele Ivan Cincione,
  • Nicola Napoli and
  • Rossella Mazzilli

13 June 2022

Background. The purpose of this study was to evaluate the effect of diet and antihyperglycemic drugs on erectile dysfunction (ED) in a setting of subjects affected by diabetes mellitus (DM) or preDM. Methods. This is a prospective observational study...

(This article belongs to the Special Issue Erectile Dysfunction (ED): Symptoms, Diagnosis and Treatment)
  • Systematic Review
  • Open Access
7 Citations
8,997 Views
20 Pages

30 November 2022

Background: There are multiple glucose-lowering drugs available as alternative initial monotherapy for type 2 diabetes patients with contraindications or intolerance to metformin. However, little comparative and systematic data are available for them...

(This article belongs to the Section Endocrinology & Metabolism)
  • Review
  • Open Access
681 Views
30 Pages

Genome-edited (GE) crops are reaching consumers faster than the analytical infrastructure designed to monitor them. Unlike transgenic crops, most GE products carry only small sequence changes and no foreign DNA, making conventional element-based poly...

(This article belongs to the Special Issue Detection Methods for Genome-Edited (GE) Crops and Commercialized Genetically Modified (GM) Crops)
  • Review
  • Open Access
40 Citations
8,336 Views
50 Pages

Anti-Diabetic Therapies and Cancer: From Bench to Bedside

  • Dimitris Kounatidis,
  • Natalia G. Vallianou,
  • Irene Karampela,
  • Eleni Rebelos,
  • Marina Kouveletsou,
  • Vasileios Dalopoulos,
  • Petros Koufopoulos,
  • Evanthia Diakoumopoulou,
  • Nikolaos Tentolouris and
  • Maria Dalamaga

20 November 2024

Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-diabetic therapies on cancer progression differing across malignancies. Among these therapies, metformin has gained attention for its potential anti-canc...

(This article belongs to the Special Issue Nutrition, Metabolism, and Obesity: Novel Strategies and Molecular Mechanisms—Future Perspectives)
  • Systematic Review
  • Open Access
7 Citations
5,866 Views
28 Pages

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis

  • Shuyan Gu,
  • Xiaoqian Hu,
  • Xuemei Zhen,
  • Lizheng Shi,
  • Hui Shao,
  • Xueshan Sun,
  • Yuxuan Gu,
  • Minzhuo Huang and
  • Hengjin Dong

16 September 2022

Background: Multiple glucose-lowering drugs are available as add-ons to metformin for a second-line treatment for type 2 diabetes. However, no systematic and comparative data are available for them in China. We aimed to compare the effects of glucose...

(This article belongs to the Section Endocrinology & Metabolism)